Commerzbank Aktiengesellschaft FI lifted its stake in CVS Health Co. (NYSE:CVS – Free Report) by 187.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,410 shares of the pharmacy operator’s stock after acquiring an additional 51,775 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in CVS Health were worth $4,994,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently made changes to their positions in the stock. Deerfield Management Company L.P. Series C purchased a new stake in CVS Health during the 2nd quarter valued at $57,584,000. CX Institutional lifted its holdings in CVS Health by 698.0% in the third quarter. CX Institutional now owns 74,609 shares of the pharmacy operator’s stock valued at $4,691,000 after acquiring an additional 65,259 shares during the period. Susquehanna Fundamental Investments LLC boosted its position in CVS Health by 27.9% in the second quarter. Susquehanna Fundamental Investments LLC now owns 665,451 shares of the pharmacy operator’s stock worth $39,302,000 after purchasing an additional 145,158 shares during the last quarter. First Hawaiian Bank grew its stake in shares of CVS Health by 30.1% during the 2nd quarter. First Hawaiian Bank now owns 100,302 shares of the pharmacy operator’s stock valued at $5,924,000 after purchasing an additional 23,213 shares during the period. Finally, Czech National Bank increased its position in shares of CVS Health by 7.2% during the 3rd quarter. Czech National Bank now owns 256,430 shares of the pharmacy operator’s stock valued at $16,124,000 after purchasing an additional 17,206 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.
CVS Health Trading Up 0.0 %
Shares of CVS Health stock opened at $56.87 on Wednesday. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The firm has a market cap of $71.39 billion, a price-to-earnings ratio of 9.99, a PEG ratio of 0.93 and a beta of 0.54. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The business has a 50-day moving average price of $59.87 and a 200-day moving average price of $60.19.
CVS Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be paid a $0.665 dividend. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.68%. CVS Health’s payout ratio is currently 46.75%.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on the stock. Royal Bank of Canada restated an “outperform” rating and set a $68.00 target price on shares of CVS Health in a research report on Wednesday, September 4th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $59.00 to $85.00 in a research note on Friday, October 4th. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft reduced their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Finally, Truist Financial lifted their price objective on CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research report on Friday, October 11th. Nine analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $74.89.
Get Our Latest Stock Report on CVS
CVS Health Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
- Five stocks we like better than CVS Health
- Compound Interest and Why It Matters When Investing
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What is Forex and How Does it Work?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.